Recommendations on the use of recombinant activated factor VII as an adjunctive treatment for massive bleeding – a European perspective

被引：0
|
作者：
Jean-Louis Vincent
Rolf Rossaint
Bruno Riou
Yves Ozier
David Zideman
Donat R Spahn
机构：
[1] Erasme Hospital,Department of Intensive Care
[2] Free University of Brussels,Department of Anaesthesiology of the University Hospital
[3] RWTH,Department of Emergency Medicine and Surgery and Department of Anesthesiology and Critical Care
[4] Hôpital Pitié-Salpêtrière,Department of Anaesthesiology
[5] Assistance Publique-Hôpitaux de Paris,undefined
[6] Université Pierre et Marie Curie,undefined
[7] Service d'Anesthésie-Réanimation Chirurgicale,undefined
[8] Hôpital Cochin,undefined
[9] Assistance publique-Hôpitaux de Paris,undefined
[10] Faculté de Medecine,undefined
[11] Paris-V,undefined
[12] Université Rene-Descartes,undefined
[13] European Resuscitation Council,undefined
[14] ERC Secretariat,undefined
[15] University Hospital Lausanne,undefined
来源：
Critical Care | / 10卷
关键词：
Orthotopic Liver Transplantation; Blunt Trauma; Fresh Freeze Plasma; Recombinant Factor VIIa; rFVIIa Administration;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
相关论文
共 50 条
  • [21] Recombinant activated factor VII in treatment of bleeding complications in thrombocytopenic patients
    Galstyan, G.
    Makarova, P.
    Polokhov, D. M.
    Orel, E.
    JOURNAL OF THROMBOSIS AND HAEMOSTASIS, 2013, 11 : 1024 - 1024
  • [22] EFFICACY AND SAFETY OF RECOMBINANT ACTIVATED FACTOR VII FOR THE TREATMENT OF PERIOPERATIVE BLEEDING
    Chang, Zhigang
    Liu, Dadong
    Liu, Yalin
    Ying, Jiaoqian
    CRITICAL CARE MEDICINE, 2019, 47
  • [23] Recombinant activated factor VII for treatment of enoxaparin-induced bleeding
    Hu, QY
    Brady, JO
    MAYO CLINIC PROCEEDINGS, 2004, 79 (06) : 827 - 827
  • [24] Usefulness of recombinant activated factor VII for massive bleeding due to trauma: a case report
    Franco Hernandez, Jose Antonio
    Niebles Velasquez, Rafael
    Cubian Gonzalez, Ignacio
    Garcia Hernandez, Alejandra
    EMERGENCIAS, 2011, 23 (01): : 73 - 74
  • [25] Use of recombinant activated factor VII in cardiac surgery for an effective treatment of severe intractable bleeding
    Vanek, T
    Straka, Z
    Hrabak, J
    Jares, M
    Brucek, PJ
    Votava, J
    JAPANESE HEART JOURNAL, 2004, 45 (05): : 855 - 860
  • [26] Use of recombinant activated factor VII
    Reingardiene, Dagmara
    Lazauskas, Robertas
    MEDICINA-LITHUANIA, 2009, 45 (03): : 248 - 253
  • [27] Recombinant activated factor VII for adjunctive hemorrhage control in trauma
    Martinowitz, U
    Kenet, G
    Segal, E
    Luboshitz, J
    Lubetsky, A
    Ingerslev, J
    Lynn, M
    JOURNAL OF TRAUMA-INJURY INFECTION AND CRITICAL CARE, 2001, 51 (03): : 431 - 438
  • [28] Use of recombinant activated factor VII for bleeding following resection of mediastinal angiosarcoma
    Arora, D.
    Mehta, Y.
    Trehan, N.
    HEART LUNG AND VESSELS, 2011, 3 (03) : 197 - 201
  • [29] Re: Guidelines for the use of recombinant activated factor VII in massive obstetric haemorrge
    Nicklin, Jim
    Perrin, Lewis
    Crandon, Alex
    Land, Russell
    Nascimento, Marcelo
    Obermair, Andreas
    AUSTRALIAN & NEW ZEALAND JOURNAL OF OBSTETRICS & GYNAECOLOGY, 2008, 48 (04): : 447 - 447
  • [30] Effective management of refractory postcardiotomy bleeding with the use of recombinant activated factor VII
    Filsoufi, Farzan
    Castillo, Javier G.
    Rahmanian, Parwis B.
    Scurlock, Corey
    Fischer, Gregory
    Adams, David H.
    ANNALS OF THORACIC SURGERY, 2006, 82 (05): : 1779 - 1783
12345